Ras signaling contributes to survival of human T-cell leukemia/lymphoma virus type 1 (HTLV-1) Tax-positive T-cells

Apoptosis

Volumn 17, Issue 3, 2012, Pages 219-228

  Stoppa, Giovanna ^a   Rumiato, Enrica ^a   Saggioro, Daniela ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Akt; Apoptosis; ERK1 2; HTLV 1; Ras; Tax

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; FARNESYL THYOSALICYLIC ACID; PROTEIN KINASE B; RAS PROTEIN; SIGNAL PEPTIDE; TAX PROTEIN; UNCLASSIFIED DRUG; PROTEIN P21;

APOPTOSIS; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; INFORMATION PROCESSING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA; CELL CULTURE; CELL TRANSFORMATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION;

EID: 84862275939     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0676-z     Document Type: Article

References (53)

1. Bos JL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49:4682-4689
2. Schubbert S, Shannon K, Bollag G (2007) Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7:295-308 (Pubitemid 46480970)
3. McCubrey JA, Steelman LS, Abrams SL et al (2008) Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3 K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia 22:708-722 (Pubitemid 351565619)
4. Scholl C, Gilliland DG, Frohling S (2008) Deregulation of signaling pathways in acute myeloid leukemia. Semin Oncol 35:336-345
5. Vajente N, Trevisan R, Saggioro D (2009) HTLV-1 Tax protein cooperates with Ras in protecting cells from apoptosis. Apoptosis 14:153-163
6. Hinuma Y, Nagata K, Hanaoka M et al (1981) Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78:6476-6480 (Pubitemid 12179735)
7. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415-7419 (Pubitemid 11131140)
8. Gessain A, Barin F, Vernant JC et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407-410 (Pubitemid 15231248)
9. Grassmann R, Aboud M, Jeang KT (2005) Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24:5976-5985 (Pubitemid 43086115)
10. Hasegawa H, Sawa H, Lewis MJ et al (2006) Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 12:466-472
11. Grassmann R, Dengler C, Muller-Fleckenstein I et al (1989) Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci USA 86:3351-3355 (Pubitemid 19129609)
12. Robek MD, Ratner L (1999) Immortalization of CD4(?) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 tax mutants expressed in a functional molecular clone. J Virol 73:4856-4865 (Pubitemid 29246746)
13. Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L (2008) The HTLV-1 tax interactome. Retrovirology 5:76
14. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70 (Pubitemid 30046295)
15. Chlichlia K, Khazaie K (2010) HTLV-1 Tax: linking transformation, DNA damage and apoptotic T-cell death. Chem Biol Interact 188:359-365
16. Taylor JM, Nicot C (2008) HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis 13:733-747
17. Saggioro D, Silic-Benussi M, Biasiotto R, D'Agostino DM, Ciminale V (2009) Control of cell death pathways by HTLV-1 proteins. Front Biosci 14:3338-3351
18. Saggioro D, Barp S, Chieco-Bianchi L (2001) Block of a mitochondrial-mediated apoptotic pathway in Tax-expressing murine fibroblasts. Exp Cell Res 269:245-255 (Pubitemid 32907166)
19. Trevisan R, Daprai L, Acquasaliente L, Ciminale V, Chieco-Bianchi L, Saggioro D (2004) Relevance of CREB phosphorylation in the anti-apoptotic function of human T-lymphotropic virus type 1 Tax protein in serum-deprived murine fibroblasts. Exp Cell Res 299:57-67 (Pubitemid 39078381)
20. Paskalis H, Felber BK, Pavlakis GN (1986) Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer. Proc Natl Acad Sci USA 83:6558-6562 (Pubitemid 17174774)
21. Smith MR, Greene WC (1990) Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4:1875-1885 (Pubitemid 120012589)
22. Hanly SM, Rimsky LT, Malim MH et al (1989) Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev 3:1534-1544
23. Sodroski JG, Rosen CA, Haseltine WA (1984) Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381-385 (Pubitemid 14089440)
24. Saggioro D, Forino M, Penzo A, Pesce M, Oliviero S, Chieco-Bianchi L (1994) Tax-induced HTLV-I LTR transcriptional activation is modulated by phosphorylation. Biochem Biophys Res Commun 205:666-673 (Pubitemid 24381678)
25. Chuang SE, Doong SL, Lin MT, Cheng AL (1997) Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene. Biochem Biophys Res Commun 238:482-486
26. Lau A, Nightingale S, Taylor GP, Gant TW, Cann AJ (1998) Enhanced MDR1 gene expression in human T-cell leukemia virus-I-infected patients offers new prospects for therapy. Blood 91:2467-2474 (Pubitemid 28155522)
27. Krishna R, Mayer LD (2000) Multidrug resistance (MDR) in cancer mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11:265-283
28. Bunn PA Jr, Foss FM (1996) T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL). J Cell Biochem Suppl 24:12-23
29. Nagata K, Ohtani K, Nakamura M, Sugamura K (1989) Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol 63:3220-3226 (Pubitemid 19181376)
30. Trevisan R, Daprai L, Paloschi L, Vajente N, Chieco-Bianchi L, Saggioro D (2006) Antiapoptotic effect of human T-cell leukemia virus type 1 tax protein correlates with its creb transcriptional activity. Exp Cell Res 312:1390-1400
31. Fiskum G, Craig SW, Decker GL, Lehninger AL (1980) The cytoskeleton of digitonin-treated rat hepatocytes. Proc Natl Acad Sci USA 77:3430-3434 (Pubitemid 10012248)
32. Herrmann C, Martin GA, Wittinghofer A (1995) Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem 270:2901-2905
33. Ikezoe T, Nishioka C, Bandobashi K et al (2007) Longitudinal inhibition of PI3 K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk Res 31:673-682 (Pubitemid 46560001)
34. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN (2005) Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 24:6719-6728 (Pubitemid 41486802)
35. Peloponese JM Jr, Jeang KT (2006) Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J Biol Chem 281:8927-8938
36. Rotblat B, Ehrlich M, Haklai R, Kloog Y (2008) The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer. Methods Enzymol 439:467-489
37. Cantrell DA (2003) GTPases and T cell activation. Immunol Rev 192:122-130
38. Sabnis AJ, Cheung LS, Dail M et al (2009) Oncogenic Kras initiates leukemia in hematopoietic stem cells. PLoS Biol 7:e59
39. von Lintig FC, Huvar I, Law P, Diccianni MB, Yu AL, Boss GR (2000) Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. Clin Cancer Res 6:1804-1810 (Pubitemid 30305075)
40. Zhang J, Wang J, Liu Y et al (2009) Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation. Blood 113:1304-1314
41. Delmas C, Heliez C, Cohen-Jonathan E et al (2002) Farnesyl-transferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation. Int J Cancer 100:43-48 (Pubitemid 34602063)
42. Smalley KS, Eisen TG (2003) Farnesyl transferase inhibitor SCH66336 is cytostatic, pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells. Int J Cancer 105:165-175 (Pubitemid 36505316)
43. Calvisi DF, Ladu S, Conner EA et al (2011) Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J Hepatol 54:311-319
44. Wu K, Bottazzi ME, de la Fuente C et al (2004) Protein profile of tax-associated complexes. J Biol Chem 279:495-508 (Pubitemid 38044851)
45. Wesierska-Gadek J, Kramer MP, Schmid G (2008) A combined treatment of HeLa cells with the farnesyl protein transferase inhibitor L-744, 832 and cisplatin significantly increases the therapeutic effect as compared to cisplatin monotherapy. J Cell Biochem 104:189-201
46. Nakada M, Uota S, Saitoh Y et al (2009) Role for protein geranylgeranylation in adult T-cell leukemia cell survival. Exp Cell Res 315:141-150
47. Kloog Y, Cox AD (2000) RAS inhibitors: potential for cancer therapeutics. Mol Med Today 6:398-402
48. Haklai R, Elad-Sfadia G, Egozi Y, Kloog Y (2008) Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice. Cancer Chemother Pharmacol 61:89-96 (Pubitemid 47512630)
49. Cleary JM, Shapiro GI (2010) Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer. Curr Oncol Rep 12:87-94
50. Knowles MA, Platt FM, Ross RL, Hurst CD (2009) Phosphatidylinositol 3-kinase (PI3 K) pathway activation in bladder cancer. Cancer Metastasis Rev 28:305-316
51. Bunney TD, Katan M (2010) Phosphoinositide signalling in cancer: beyond PI3 K and PTEN. Nat Rev Cancer 10:342-352
52. Hiraragi H, Michael B, Nair A, Silic-Benussi M, Ciminale V, Lairmore M (2005) Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis. J Virol 79:9449-9457 (Pubitemid 41022289)
53. Andresen V, Pise-Masison CA, Sinha-Datta U et al (2011) Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles. Blood 118:1549-1559